STRATA Skin Sciences, Inc. (SSKN)

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues	2.8	2.4		3.6	3.5	2.0		2.0
Revenue growth	-20.7%	19.5%		78.2%	82.5%	72.0%		12.5%
Gross profit	1.1	1.2		2.0	1.7	1.1		1.2
Gross margin	38.2%	50.8%		56.3%	48.5%	55.4%		58.9%
Sales and marketing	0.6	0.4		0.5	0.5	0.3		0.2
Research and development	0.1	0.1		0.1	0.1	0.0		0.0
EBITDA	0.6	0.9		1.5	1.4	0.9		0.9
EBITDA margin	21.6%	39.0%		41.3%	39.5%	45.8%		46.9%
Depreciation and amortization	0.2	0.2			0.3	0.2
EBIT	0.4	0.7		1.5	1.1	0.7		0.9
EBIT margin	14.9%	31.4%		41.3%	31.7%	37.5%		46.9%
Pre-tax income
Pre-tax margin
Net income	0.4	0.7			1.1	0.7
Net margin	14.9%	31.4%			31.7%	37.5%

Total assets
ROA

Revenue Mix	33.9%	31.2%		37.9%	38.7%	28.0%		25.9%
EBIT Mix